Please login to the form below

Not currently logged in
Email:
Password:

Chiesi launches Flogoprofen website

Targets consumers and health professionals in Spain
Chiesi flogoprofen website

Chiesi Spain has unveiled a dedicated website for its anti-inflammatory drug Flogoprofen (etofenamate).

The new website – www.flogoprofen.es – is aimed at both consumers and health professionals authorised to prescribe drugs.

In addition to offering readers a better understanding of Flogoprofen and its uses, the site will look into the lesser-known aspects of pain, along with providing exercise videos aimed at showing the public how to prevent and relieve it.
Chiesi Spain said the website content is designed to encourage 'total interactivity' with its users, and will evolve as time goes on and user preferences become clear.

“We are working to give people a website that serves as a comprehensive reference point for queries on topics related to musculoskeletal pain,” said Elizabeth Font, product manager at Chiesi Flogoprofen Spain.

Although still awaiting the bulk of its planned content, the section of the website aimed at health professionals already includes suggestions on how best to promote Flogoprofen to patients, for instance by underlining its popularity, with 25 million units sold over the last 10 years.

The website will feature a blog aimed at amateur sportsmen and women, and the videos can also be seen on YouTube.

Chiesi has been active in Spain since 1995, when it acquired Laboratorios Wassermann. The company has also since acquired Laboratorios Dreiman Chiesi and Advent International, and has more than 200 employees in Spain today.

In addition to Flogoprofen, Chiesi Spain manufactures drugs for the treatment of cardiovascular, neonatal and respiratory conditions.

Article by
Tara Craig

2nd May 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics